Drug Therapy

Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 1: A Status Report on the Disease State, General Measures, and Adjunctive Skin Care

Rosacea is a common clinical diagnosis that encompasses a variety of presentations, predominantly involving the centrofacial skin. Reported to present most commonly in adults of Northern European heritage with fair skin, rosacea can affect males and females of all ethnicities and skin types. Pathophysiologic mechanisms that appear to correlate with the manifestation of rosacea have been the focus of multiple research studies, with outcomes providing a better understanding of why some individuals are affected and how their visible signs and symptoms develop. A better appreciation of the pathophysiologic mechanisms and inflammatory pathways of rosacea has allowed therapeutic strategies to be optimally incorporated. Part 1 of this 5-part series discusses the rosacea disease state with an emphasis on clinical correlation, reviews adjunctive skin care for cutaneous rosacea, and provides management caveats.

Test your knowledge on consensus recommendations for rosacea with MD-IQ: the medical intelligence quiz. Click here to answer 5 questions.


 

Next Article:

Product News: 09 2013

Recommended for You

Expert Content

Quizzes from MD-IQ

Research Summaries from ClinicalEdge

Related Articles

  • Blog

    Antibiotic Use: Yet Another Threat?

    The issue of increasing antibiotic resistance has become a serious global threat. The World Health Organization proclaimed that World Health Day...

  • Article

    Rosacea Fulminans

    We review rosacea fulminans, a rare condition that may cause facial scarring and disfigurement. All physicians and health care professionals must...

  • Commentary

    Probiotics in Acne and Rosacea

    Our understanding of the pathophysiology of acne and rosacea continues to evolve, leading to new therapeutic targets and the development of...